Address
Email address
Phone number
Website
Name
Osaühing Berlin-Chemie Menarini Eesti
Registry code
11100035
VAT number
EE100949993
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
31.01.2005 (19)
Financial year
01.01-31.12
Capital
22 369.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
15 270 621 €
599 744 €
4%
-
6 538 875 €
25
Submitted
No tax arrears
9%
8%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Kristi Reimann 16.02.1969 (55) | - | Procurator | - | |
| Edita Grinyte 10.01.1968 (56) | - | Board member | - |
| 2019 20.05.2020 | 2020 26.04.2021 | 2021 06.05.2022 | 2022 25.05.2023 | 2023 17.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 10 266 975 € | 9 754 347 € | 12 873 830 € | 13 750 464 € | 15 270 621 € |
| Net profit (loss) for the period | 1 088 770 € | 976 614 € | 945 131 € | 676 149 € | 599 744 € |
| Profit Margin | 11% | 10% | 7% | 5% | 4% |
| Current Assets | 5 175 271 € | 7 107 822 € | 8 450 571 € | 8 868 597 € | 7 307 119 € |
| Fixed Assets | 37 930 € | 29 515 € | 21 119 € | 30 530 € | 41 148 € |
| Total Assets | 5 213 201 € | 7 137 337 € | 8 471 690 € | 8 899 127 € | 7 348 267 € |
| Current Liabilities | 851 964 € | 1 799 486 € | 2 198 708 € | 1 959 996 € | 809 392 € |
| Non Current Liabilities | 0 € | 0 € | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 4 361 237 € | 5 337 851 € | 6 272 982 € | 6 939 131 € | 6 538 875 € |
| Employees | 28 | 30 | 27 | 25 | 25 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 7 577 388.71 € | 493 556.32 € | 178 361.7 € | 26 |
| 2023 Q4 | 7 801 369.06 € | 468 382.24 € | 178 155.69 € | 24 |
| 2023 Q3 | 6 804 071.04 € | 677 935.08 € | 153 110.99 € | 25 |
| 2023 Q2 | 6 790 616.07 € | 565 311.47 € | 286 183.25 € | 24 |
| 2023 Q1 | 6 644 893.52 € | 434 333.04 € | 169 817.38 € | 26 |
| 2022 Q4 | 7 170 126.02 € | 459 342.91 € | 159 942.04 € | 25 |
| 2022 Q3 | 6 047 949.91 € | 386 755.52 € | 138 207.5 € | 26 |
| 2022 Q2 | 6 373 488.05 € | 496 279.41 € | 252 301.31 € | 24 |
| 2022 Q1 | 6 074 167.94 € | 380 563.99 € | 156 669.59 € | 28 |
| 2021 Q4 | 6 556 215.09 € | 416 037.66 € | 148 785.53 € | 29 |
| 2021 Q3 | 4 997 926.85 € | 400 678.08 € | 168 963.3 € | 27 |
| 2021 Q2 | 5 128 913.87 € | 360 238.79 € | 225 899.53 € | 27 |
| 2021 Q1 | 4 939 783 € | 326 490.33 € | 152 442.18 € | 31 |
| 2020 Q4 | 5 490 469.81 € | 363 422.11 € | 150 248.38 € | 30 |
| 2020 Q3 | 4 762 845.06 € | 347 230.94 € | 159 925.24 € | 29 |
| 2020 Q2 | 5 219 174.56 € | 403 161.34 € | 209 931.16 € | 27 |
| 2020 Q1 | 4 778 558.49 € | 348 676.76 € | 146 434.11 € | 28 |
